| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.007 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.009 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.01 |